Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2000-10-12
2004-11-23
Leffers, Gerry (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C536S023100, C536S023400, C530S350000, C530S300000
Reexamination Certificate
active
06821736
ABSTRACT:
FIELD OF THE INVENTION
The field of this invention is human proteins involved in the inhibition of apoptosis, or programmed cell death.
BACKGROUND
Cellular apoptosis, or programmed cell death, may be initiated by a variety of different stimuli including viral infection, certain cell-culture conditions, cell-cell signaling, cytokines, etc. Elucidation of signal transduction pathways leading to apoptosis would provide valuable insight into a variety of pathogenic mechanisms. Accordingly, the ability to exogenously modulate the induction of apoptosis would yield therapeutic application for numerous clinical indications. In addition, components of such pathways would provide valuable targets for automated, cost-effective, high throughput drug screening and hence would have immediate application in domestic and international pharmaceutical and biotechnology drug development programs.
Relevant Literature
Rothe et al. (1994) Cell 78, 681-692, report the existence of tumor necrosis factor (TNF) receptor associated proteins which co-immunoprecipitate with a TNF receptor; see also Rothe, et al., pending U.S. patent application Ser. No: 08/446,915 now U.S Pat. No. 5,741,677. Roy, et al. (1995) Cell 80, 167-178 disclose the gene for a human neuronal apoptosis inhibitory protein. Birnbaum et al. (1994) J Virol 68, 2521-2528 disclose an inhibitor of apoptosis (iap) gene, Op-iap from the Orgyia pseudotsugata nuclear polyhedrosis virus (OpMNPV) with sequence similarity to two other viral genes: Cp-iap derived from Cydia pomonella granulosis virus (CpGV), and iap derived from the Autographa californica nuclear polyhedrosis virus (AcMNPV). Clem and Miller (1994), in Apoptosis II: The Molecular Basis of Apoptosis in Disease, pp 89-110, Cold Spring Harbor Laboratory Press, provide a recent review of apoptosis regulation by insect viruses.
SUMMARY OF THE INVENTION
The invention provides methods and compositions relating to novel human cellular inhibitor of apoptosis proteins (c-IAP). The subject proteins comprise a series of defined structural domain repeats and/or a RING finger domain; in particular, at least two of a first domain repeat comprising SEQUENCE ID NO: 5 or 6; a second domain repeat comprising SEQUENCE ID NO: 7 or 8; and a third domain repeat comprising SEQUENCE ID NO: 9 or 10; and/or a RING finger domain comprising SEQUENCE ID NO: 11 or 12, or a consensus sequences derived from these human genes. The proteins provide a c-IAP specific function, with preferred proteins being capable of modulating the induction of apoptosis; for example, by binding a human tumor necrosis factor receptor associated factor, TRAF. The compositions include nucleic acids which encode the subject c-IAP and hybridization probes and primers capable of hybridizing with the disclosed c-IAP genes.
The invention includes methods of using the subject compositions in therapy (e.g. gene therapy to enhance expression of a c-IAP gene), in diagnosis (e.g. genetic hybridization screens for c-IAP gene mutations, and in the biopharmaceutical industry (e.g. reagents for increasing yields of recombinant protein by enhancing host cell survival in culture, for screening chemical libraries for lead compounds for a pharmacological agent useful in the diagnosis or treatment of disease associated with apoptosis regulation, etc.).
REFERENCES:
patent: 5919912 (1999-07-01), Korneluk et al.
Takahashi et al. J. Biol. Chem. Apr. 3, 1998, vol. 273, pp. 7787-7790.*
Marshall, E (1995) Science 269:1050-1055.
Vile et al. (1995) Targeted Gene Therapy 9: 190-199.
Birnbaum et al. (1994) J. Virol. 68: 2521-2528.
M. Rothe et al. (1995) Cell 83: 1243-1252.
A Fernandez et al. (1994) Cancer Bulletin 46: 153-160.
DL Vaux et al. (1996) Proc. Natl. Acad. Sci. USA 93: 2239-2244.
L Hillier et al. (Apr. 5, 1995) EST Accession No. R07927. Accessed Feb. 21, 1997.
L Hillier et al. (Mar. 27, 1995) EST accession No. T96284. Accessed Feb. 21, 1997.
Goeddel David V
Rothe Mike
Amgen Inc.
Leffers Gerry
Osman Richard Aron
LandOfFree
Inhibitors of apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3341384